학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 90건 | 목록 1~10
Academic Journal
Martin-Liberal J; Catalan Institute of Oncology (ICO), Barcelona, Spain.; Garralda E; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; García-Donas J; Centro Integral Oncológico Clara Campal (HM CIOCC), Madrid, Spain.; Soto-Castillo JJ; Catalan Institute of Oncology (ICO), Barcelona, Spain.; Mussetti A; Catalan Institute of Oncology (ICO), Barcelona, Spain.; Codony C; Institute of Biomedical Research of Bellvitge (IDIBELL), Barcelona, Spain.; Martin-Lluesma S; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Muñoz S; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Galvao V; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Lostes J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Rotxes M; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Prat-Vidal C; Banc de Sang i Teixits (BST), Barcelona, Spain.; Palomero J; Banc de Sang i Teixits (BST), Barcelona, Spain.; Muñoz A; Institute of Biomedical Research of Bellvitge (IDIBELL), Barcelona, Spain.; Moreno R; Catalan Institute of Oncology (ICO), Barcelona, Spain.; Del Muro XG; Catalan Institute of Oncology (ICO), Barcelona, Spain.; Sureda A; Catalan Institute of Oncology (ICO), Barcelona, Spain.; Alemany R; Catalan Institute of Oncology (ICO), Barcelona, Spain.; Gros A; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Piulats JM; Catalan Institute of Oncology (ICO), Barcelona, Spain.
Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE
Academic Journal
Arranz Arija JA; Hospital General Universitario Gregorio Marañón, Madrid, Spain. jarranza.oncomed@gmail.com.; Del Muro XG; Hospital Duran I Reynals, Institut Català D'Oncologia L'Hospitalet (ICO), Barcelona, Spain.; Caro RL; Hospital Universitario Virgen de Las Nieves, Instituto de Investigación Biosanitaria Ibs, Granada, Spain.; Méndez-Vidal MJ; Hospital Universitario Reina Sofía, Córdoba, Spain.; Pérez-Valderrama B; Hospital Universitario Virgen del Rocío, Seville, Spain.; Aparicio J; Hospital Universitario I Politècnic La Fe, Valencia, Spain.; Climent Durán MÁ; Instituto Valenciano de Oncología, Valencia, Spain.; Caballero Díaz C; Consorcio Hospital General Universitario de Valencia, Valencia, Spain.; Durán I; Hospital Universitario Marqués de Valdecilla, Santander, Spain.; González-Billalabeitia E; Hospital Universitario 12 de Octubre, IMAS 12, UCAM, Madrid, Spain.
Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE
Academic Journal
Boormans JL; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands. Electronic address: j.boormans@erasmusmc.nl.; Sylvester R; European Association of Urology Guidelines Office, Brussels, Belgium.; Anson-Cartwright L; Department of Surgery (Urology), Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Glicksman RM; European Association of Urology, Arnhem, The Netherlands.; Hamilton RJ; Department of Surgery (Urology), Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Hahn E; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Daugaard G; Department of Oncology 5073, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Lauritsen J; Department of Oncology 5073, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Wagner T; Department of Oncology 5073, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Avuzzi B; Radiation Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Nicolai N; Urology Unit, Fondazione IRCCS Instituto Nazionale dei Tumori, Milan, Italy.; Del Muro XG; Department of Medical Oncology, Hospital Universitario y Politécnico La Fe, Valencia, Spain(1).; Aparicio J; Department of Medical Oncology, Hospital Universitario y Politécnico La Fe, Valencia, Spain(1).; Stalder O; Clinical Trials Unit Bern, University of Bern, Bern, Switzerland.; Rothermundt C; Department of Medical Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.; Fischer S; Department of Medical Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.; Laguna MP; Department of Urology, Istanbul Medipol University, Istanbul, Turkey.
Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE
Academic Journal
Climent MÁ; Valencian Institute of Oncology, Valencia, Spain.; Álvarez C; Hospital Universitario Central de Asturias, Oviedo, Spain.; Morales R; Vall d'Hebron University Hospital, Barcelona, Spain.; Maroto P; Hospital Universitari de La Santa Creu I Sant Pau, Barcelona, Spain.; Rodríguez-Vida A; Hospital del Mar-CIBERONC, IMIM Research Institute, Barcelona, Spain.; Méndez-Vidal MJ; Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Reina Sofia University Hospital (HURS), Cordoba, Spain.; Del Muro XG; Catalan Institute of Oncology, Barcelona, Spain.; Puente J; Hospital Universitario Clínico San Carlos, Madrid, Spain.; Láinez N; University Hospital of Navarra, Pamplona, Spain.; Vázquez S; Hospital Universitario Lucus Augusti, Lugo, Spain.; Castellano D; Hospital 12 de Octubre, Madrid, Spain.; Lang CG; Merck S.L.U., an Affiliate of Merck KGaA, Madrid, Spain.; Wang J; Pfizer, Cambridge, MA, USA.; di Pietro A; Pfizer Srl, Milan, Italy.; Davis C; Pfizer Translational Oncology, La Jolla, CA, USA.; Sanz-Castillo B; Pfizer Oncology, Madrid, Spain.; Bolós MV; Pfizer Oncology, Madrid, Spain.; Valderrama BP; Virgen del Rocío University Hospital, Seville, Spain. bpvalderrama@gmail.com.
Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE
Academic Journal
Lauritsen J; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Denmark.; Sauvé N; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.; Tryakin A; Department of Chemotherapy, N.N.Blokhin Russian Cancer Research Center, Moscow, Russia.; Jiang DM; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.; Huddart R; Institute of Cancer Research and Royal Marsden Hospital, Downs Road, Sutton, Surrey, UK.; Heng DYC; Division of Medical Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada.; Terbuch A; Division of Oncology, Medical University of Graz, Graz, Austria.; Winquist E; Department of Oncology, University of Western Ontario and London Health Sciences Centre, London, ON, Canada.; Chovanec M; 2nd Department of Oncology, Faculty of Medicine, Comenius University, National Cancer Institute, Bratislava, Slovakia.; Hentrich M; Department of Hematology/Oncology, Red Cross Hospital, Munich, Germany.; Fankhauser CD; University of Zurich, Zurich, Switzerland.; University of Lucerne, Lucerne, Switzerland.; Shamash J; Department of Oncology, St Bartholomew's Hospital, London, UK.; Del Muro XG; Department of Medical Oncology, Catalan Institute of Oncology, Barcelona, Spain.; Vaughn D; Division of Hematology/Oncology, Abramson Cancer Center at the University of Pennsylvania, Philadelphia, PA, USA.; Heidenreich A; Department of Urology, Uro-Oncology, Robot Assisted and Specialized Urologic Surgery, University Hospital Cologne, Cologne, Germany.; Sternberg CN; Englander Institute for Precision Medicine, Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York-Presbyterian, New York, NY, USA.; Sweeney C; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.; Necchi A; Vita-Salute San Raffaele University, Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy.; Bokemeyer C; Department of Oncology, Hematology and BMT with section Pneumonology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.; Bandak M; Department of Consulting and Research, International Drug Development Institute, Louvain-la-Neuve, Belgium.; Jandari A; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.; Collette L; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.; Gillessen S; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.; University of Southern Switzerland, Lugano, Switzerland.; Beyer J; Department of Medical Onccology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. joerg.beyer@insel.ch.; Daugaard G; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Denmark.
Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Academic Journal
Casali PG; Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Department of Oncology and Hemato-oncology University of Milan, Milan, Italy.; Blay JY; Centre Leon Berard and UCBL1, Lyon, France.; Abecassis N; Instituto Portugues de Oncologia de Lisboa Francisco Gentil, EPE, Lisbon, Portugal.; Bajpai J; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.; Bauer S; Department of Medical Oncology, Interdisciplinary Sarcoma Center, West German Cancer Center, University of Duisburg-Essen, Essen, Germany.; Biagini R; Department of Oncological Orthopedics, Musculoskeletal Tissue Bank, IFO, Regina Elena National Cancer Institute, Rome, Italy.; Bielack S; Klinikum Stuttgart-Olgahospital, Stuttgart, Germany.; Bonvalot S; Department of Surgery, Institut Curie, Paris, France.; Boukovinas I; Bioclinic Thessaloniki, Thessaloniki, Greece.; Bovee JVMG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Boye K; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; Brodowicz T; Vienna General Hospital (AKH), Medizinische Universität Wien, Vienna, Austria.; Buonadonna A; Centro di Riferimento Oncologico di Aviano, Aviano, Italy.; De Álava E; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain; Department of Normal and Pathological Cytology and Histology, School of Medicine, University of Seville, Seville, Spain.; Dei Tos AP; Department of Pathology, Azienda Ospedale Università Padova, Padova, Italy.; Del Muro XG; Integrated Unit ICO Hospitalet, HUB, Barcelona, Spain.; Dufresne A; Département d'Oncologie Médicale, Centre Leon Berard, Lyon, France.; Eriksson M; Skane University Hospital-Lund, Lund, Sweden.; Fedenko A; P. A. Herzen Cancer Research Institute, Moscow, Russian Federation.; Ferraresi V; Sarcomas and Rare Tumors Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.; Ferrari A; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Frezza AM; Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.; Gasperoni S; Department of Oncology and Robotic Surgery, Azienda Ospedaliera Universitaria Careggi, Florence, Italy.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands.; Gouin F; Centre Leon-Berard Lyon, Lyon, France.; Grignani G; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy.; Haas R; Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Radiotherapy, Leiden University Medical Centre, Leiden, The Netherlands.; Hassan AB; Oxford University Hospitals NHS Foundation Trust and University of Oxford, Oxford, UK.; Hindi N; Department of Medical Oncology, Fundación Jimenez Diaz, University Hospital, Advanced Therapies in Sarcoma Lab, Madrid, Spain.; Hohenberger P; Mannheim University Medical Center, Mannheim, Germany.; Joensuu H; Helsinki University Hospital (HUH) and University of Helsinki, Helsinki, Finland.; Jones RL; Sarcoma Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK.; Jungels C; Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.; Jutte P; University Medical Center Groningen, Groningen, The Netherlands.; Kasper B; Mannheim University Medical Center, Mannheim, Germany.; Kawai A; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan.; Kopeckova K; University Hospital Motol, Prague, Czech Republic.; Krákorová DA; Masaryk Memorial Cancer Institute, Brno, Czech Republic.; Le Cesne A; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.; Le Grange F; Department of Oncology, University College London Hospitals NHS Foundation Trust (UCLH), London, UK.; Legius E; Department for Human Genetics, University Hospitals Leuven, KU Leuven, Leuven, Belgium.; Leithner A; Department of Orthopaedics and Trauma, Medical University of Graz, Graz, Austria.; Lopez-Pousa A; Medical Oncology Department, Hospital Universitario Santa Creu i Sant Pau, Barcelona, Spain.; Martin-Broto J; Department of Medical Oncology, Fundación Jimenez Diaz, University Hospital, Advanced Therapies in Sarcoma Lab, Madrid, Spain.; Merimsky O; Aviv Sourasky Medical Center (Ichilov), Tel Aviv, Israel.; Messiou C; Department of Radiology, Royal Marsden Hospital and Institute of Cancer Research, London, UK.; Miah AB; Department of Oncology, Royal Marsden Hospital and Institute of Cancer Research, London, UK.; Mir O; Department of Ambulatory Cancer Care, Gustave Roussy, Villejuif, France.; Montemurro M; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; Morosi C; Department of Radiology, IRCCS Foundation National Cancer Institute, Milan, Italy.; Palmerini E; Department of Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.; Pantaleo MA; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria, di Bologna, Bologna, Italy.; Piana R; Azienda Ospedaliero, Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.; Piperno-Neumann S; Department of Medical Oncology, Institut Curie, Paris, France.; Reichardt P; Helios Klinikum Berlin Buch, Berlin, Germany.; Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Safwat AA; Aarhus University Hospital, Aarhus, Denmark.; Sangalli C; Department of Radiotherapy, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Sbaraglia M; Department of Pathology, Azienda Ospedale Università Padova, Padova, Italy.; Scheipl S; Department of Orthopaedics and Trauma, Medical University of Graz, Graz, Austria.; Schöffski P; Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Strauss D; Department of Surgery, Royal Marsden Hospital, London, UK.; Strauss SJ; Department of Oncology, University College London Hospitals NHS Foundation Trust (UCLH), London, UK.; Hall KS; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; Trama A; Department of Research, Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Unk M; Institute of Oncology of Ljubljana, Ljubljana, Slovenia.; van de Sande MAJ; Department of Orthopedic Surgery, Leiden University Medical Center, Leiden, The Netherlands.; van der Graaf WTA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, The Netherlands.; van Houdt WJ; Department of Surgical Oncology, the Netherlands Cancer Institute, Amsterdam, The Netherlands.; Frebourg T; Department of Genetics, Normandy Center for Genomic and Personalized Medicine, Normandie University, UNIROUEN, Inserm U1245 and Rouen University Hospital, Rouen, France.; Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan, Italy.; Stacchiotti S; Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan, Italy.; Miah AB; Department of Oncology, Royal Marsden Hospital and Institute of Cancer Research, London, UK.; Dei Tos AP; Department of Pathology, Azienda Ospedale Università Padova, Padua, Italy.; Abecassis N; Instituto Portugues de Oncologia de Lisboa Francisco Gentil, EPE, Lisbon, Portugal.; Bajpai J; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.; Bauer S; Department of Medical Oncology, Interdisciplinary Sarcoma Center, West German Cancer Center, University of Duisburg-Essen, Essen, Germany.; Biagini R; Department of Oncological Orthopedics, IRCCS Regina Elena National Cancer Institute, Rome, Italy.; Bielack S; Klinikum Stuttgart-Olgahospital, Stuttgart, Germany.; Blay JY; Centre Leon Berard and UCBL1, Lyon, France.; Bolle S; Radiation Oncology Department, Gustave Roussy, Villejuif, France.; Bonvalot S; Department of Surgery, Institut Curie, Paris, France.; Boukovinas I; Bioclinic Thessaloniki, Thessaloniki, Greece.; Bovee JVMG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Boye K; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; Brennan B; Paediatric Oncology, Royal Manchester Children's Hospital, Manchester, UK.; Brodowicz T; Vienna General Hospital (AKH), Medizinische Universität Wien, Vienna, Austria.; Buonadonna A; Centro di Riferimento Oncologico di Aviano, Aviano, Italy.; De Álava E; Hospital Universitario Virgen del Rocio-CIBERONC, Seville, Spain; Department of Normal and Pathological Cytology and Histology, School of Medicine, University of Seville, Seville, Spain.; Del Muro XG; Integrated Unit ICO Hospitalet, HUB, Barcelona, Spain.; Dufresne A; Département d'Oncologie Médicale, Centre Leon Berard, Lyon, France.; Eriksson M; Skane University Hospital-Lund, Lund, Sweden.; Fagioli F; Paediatric Onco-Haematology Department, Regina Margherita Children's Hospital, Department of Public Health and Pediatrics, University of Turin, Turin, Italy.; Fedenko A; P. A. Herzen Cancer Research Institute, Moscow, Russian Federation.; Ferraresi V; Sarcomas and Rare Tumors Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.; Ferrari A; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Frezza AM; Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.; Gasperoni S; Azienda Ospedaliera Universitaria Careggi Firenze, Florence, Italy.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands.; Gouin F; Centre Leon-Berard Lyon, Lyon, France.; Grignani G; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy.; Haas R; Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Radiotherapy, Leiden University Medical Centre, Leiden, The Netherlands.; Hassan AB; Oxford University Hospitals NHS Foundation Trust and University of Oxford, Oxford, UK.; Hecker-Nolting S; Klinikum Stuttgart-Olgahospital, Stuttgart, Germany.; Hindi N; Department of Medical Oncology, Fundación Jimenez Diaz University Hospital, Advanced Therapies in Sarcoma Lab, Madrid, Spain.; Hohenberger P; Mannheim University Medical Center, Mannheim, Germany.; Joensuu H; Helsinki University Hospital (HUH) and University of Helsinki, Helsinki, Finland.; Jones RL; Sarcoma Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK.; Jungels C; Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.; Jutte P; University Medical Center Groningen, Groningen, The Netherlands.; Kager L; St. Anna Children's Hospital, Department of Pediatrics and Medical University Vienna Children's Cancer Research Institute, Vienna, Austria.; Kasper B; Mannheim University Medical Center, Mannheim, Germany.; Kawai A; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan.; Kopeckova K; University Hospital Motol, Prague, Czech Republic.; Krákorová DA; Masaryk Memorial Cancer Institute, Brno, Czech Republic.; Le Cesne A; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.; Le Grange F; Department of Oncology, University College London Hospitals NHS Foundation Trust (UCLH), London, UK.; Legius E; Department for Human Genetics, University Hospitals Leuven, KU Leuven, Leuven, Belgium.; Leithner A; Department of Orthopaedics and Trauma, Medical University of Graz, Graz, Austria.; Lopez-Pousa A; Medical Oncology Department, Hospital Universitario Santa Creu i Sant Pau, Barcelona, Spain.; Martin-Broto J; Department of Medical Oncology, Fundación Jimenez Diaz University Hospital, Advanced Therapies in Sarcoma Lab, Madrid, Spain.; Merimsky O; Tel Aviv Sourasky Medical Center (Ichilov), Tel Aviv, Israel.; Messiou C; Department of Radiology, Royal Marsden Hospital and Institute of Cancer Research, London, UK.; Mir O; Department of Ambulatory Cancer Care, Gustave Roussy, Villejuif, France.; Montemurro M; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; Morland B; Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.; Morosi C; Department of Radiology, IRCCS Foundation National Cancer Institute, Milan, Italy.; Palmerini E; Department of Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.; Pantaleo MA; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria, di Bologna, Bologna, Italy.; Piana R; Azienda Ospedaliero, Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.; Piperno-Neumann S; Department of Medical Oncology, Institut Curie, Paris, France.; Reichardt P; Helios Klinikum Berlin Buch, Berlin, Germany.; Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Safwat AA; Aarhus University Hospital, Aarhus, Denmark.; Sangalli C; Department of Radiotherapy, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Sbaraglia M; Department of Pathology, Azienda Ospedale Università Padova, Padua, Italy.; Scheipl S; Department of Orthopaedics and Trauma, Medical University of Graz, Graz, Austria.; Schöffski P; Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Strauss D; Department of Surgery, Royal Marsden Hospital, London, UK.; Strauss S; Department of Oncology, University College London Hospitals NHS Foundation Trust (UCLH), London, UK.; Sundby Hall K; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; Trama A; Department of Research, Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Unk M; Institute of Oncology of Ljubljana, Ljubljana, Slovenia.; van de Sande MAJ; Department of Orthopedic Surgery, Leiden University Medical Center, Leiden, The Netherlands.; van der Graaf WTA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, The Netherlands.; van Houdt WJ; Department of Surgical Oncology, the Netherlands Cancer Institute, Amsterdam, The Netherlands.; Frebourg T; Department of Genetics, Normandy Center for Genomic and Personalized Medicine, Normandie Univ, UNIROUEN, Inserm U1245 and Rouen University Hospital, Rouen, France.; Casali PG; Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Department of Oncology and Hemato-oncology University of Milan, Milan, Italy.; Stacchiotti S; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] del Muro, XG
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어